Is the paper you need stuck behind a paywall?
Five websites every researcher should know to access any research paper for free
@AcademicChatter@OpenAcademics
I've been doing a lot of UTI Dx St, but blood culture Dx St is extremely important and not nearly as well studied, especially in immunocompromised pts. Thanks to @laurengroft for all her work on this!
Do you have questions about our programs? 🤔
Attend our zoom open houses!
Here is the breakdown of which programs will be present each day:
11/10 - ID, pediatrics, SOT, AmCare, HSPA
11/16 - Cardiology, Critical care, Oncology
11/18 - PGY1, palliative care, EM, geriatrics
❗️LESS THAN 1/3 of hospitals have ATRA immediately available for APL patients❗️
This is arguably the most urgent medication in all of oncology. This must change. No access = early mortality.
👀our team's latest paper in @JNCCN - https://t.co/5lL0RTvMpw
#TwitteRx#leusm 1/2
@umresfelrx *focus on relationships*! spending your first few months/year establishing relationships with your nurses/physicians/etc will make you & your team SO much more successful in providing care to your patients! you’ll have lots of time to optimize guidelines/policies/etc afterward 😊
Excited to present my labor-o-love research project with @CieraPatzke & co at #HOPAAC21 today from 2-4pm CDT! Sneak peak 👇 but can't get enough? Come find me at TR167 🤓
Kudos to @HOPArx for making the annual meeting FREE for residents and trainees 🙌🏼 I encourage all of my residents & students to attend!
The major challenge is the $400 cost for non-trainees when most hospitals cut their educational funding this year 😫💸 #TwitteRx#oncopharm
Feeling myself in low spirits lately, missing holiday tradition. so i ask, what am I grateful for?
1️⃣my health so I can care for patients🤗
2️⃣covid vaccine💉cant wait for mine!
3️⃣marrying @CBernhardi in 30 days! COVID cant cancel love
hang in there everyone, we’re almost there💙
📣 heyyy #Oncopharm community! @UMGCCC is expanding their oncology clinical pharmacy specialist group! check us out, we’d love to have you join our incredible team ! 🙋🏻♀️ https://t.co/HCNyhJXAo9
Dear ID friends,
I would like to formally welcome you to the world of Heme/Onc, where the FDA makes decisions without appropriate data and no one can pronounce the drugs!
Welcome to the party!
Reviewer on a protocol for @UMGCCC clinical research committee today and i’m reminded of how in AWE I am of the oncology research world! 👏🏻amazing use of pharmacology to overcome tumor resistance in R/R disease - (hopefully) coming soon to treatments near you! #oncopharm